Barinthus Biotherapeutics
Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates.
39 employees · est. 2016 · Oxford, United Kingdom
GlobeImmune, Inc. is the older company (1995 vs 2016).
Side-by-Side Comparison
| Metric | GlobeImmune, Inc. | Barinthus Biotherapeutics |
|---|---|---|
| Founded | ||
| Founded | 1995 older | 2016 |
| Headquarters | ||
| Headquarters | Louisville, United States | Oxford, United Kingdom |
| Employees | ||
| Employees | 12 | 39 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | Acquired |
| Total Funding | ||
| Total Funding | $128.46M | $146.66M |
| Funding Rounds | ||
| Funding Rounds | 9 | 7 |
| Services | ||
| Services | Not tracked yet | Development of antigen-specific immunotherapies, Phase 1b/2 clinical trials, Pipeline management for autoimmune diseases and chronic viral infections, Biopharmaceutical research and development |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with autoimmune and inflammatory conditions, Patients with chronic viral infections, Healthcare providers, Oncologists |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Tarmogen Platform, Cancer Treatment, Infectious Diseases, Immunotherapy, Oncology Product Candidates, Strategic Collaborations, Gilead Sciences, Celgene Corporation, Antiviral Therapies, Targeted Molecular Immunotherapy, Clinical Evaluation, Immune System Activation | T-cell Immunotherapeutics, Chronic Infectious Diseases, Autoimmunity, Cancer Treatment, ChAdOx Technology, MVA Boost Vector, SNAP-TI Platform, SNAP-CI Platform, CD8+ T Cells, Chronic HBV Treatment, Celiac Disease Treatment, Prostate Cancer Treatment, Viral Vaccine Development, Biopharmaceutical Innovation, Immunotherapeutic Pipeline |
| Website | ||
| Website | globeimmune.com | barinthusbio.com |
About GlobeImmune, Inc.
GlobeImmune, Inc. is a *biopharmaceutical* company founded in 1995 in the United States. The company focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen ® platform. Tarmogens activate the immune system by stimulating T cells that destr...
About Barinthus Biotherapeutics
Barinthus Biotherapeutics, founded in 2016, is a United Kingdom-based clinical-stage biopharmaceutical company that is innovating in the realms of Biotechnology, Health and Wellness, and Pharmaceutical industries. The company specializes in developing novel T-cell immunotherapeutic candidates aimed...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at GlobeImmune, Inc. and Barinthus Biotherapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at GlobeImmune, Inc. and Barinthus Biotherapeut... — by email.
Frequently Asked Questions
Compare GlobeImmune, Inc. with someone else
Start typing a company name or domain.